NEWS

NEWS 2022.3.28 Rebirthel is nominated as a finalist in three categories for Informa Pharma Intelligence Awards

Informa Pharma Intelligence is the Japanese version of Scrips Awards which is world famous with...

NEWS 2022.3.3 Rebirthel won the Kyoto University Award at 3rd Kyoto University LifeScience Showcase 2022 @ San Diego

Graduate School of Medicine, Kyoto University has its research center on the campus of Universi...

NEWS , Press release 2021.12.16 Rebirthel and Otsuka Sign Licensing Agreement for iPSC-derived CAR-T / TCR-T Production Technology

Rebirthel Co., Ltd. announces that it entered into an exclusive commercial licensing agreement ...

Media , NEWS 2021.10.22 Rebirthel was featured on Nihon Keizai Shimbun (Japanese newspaper)

In the morning edition of Nihon Keizai Shimbun on October 22nd, 2021 (Page 18, Technology), Reb...

NEWS 2021.10.15 Japan Healthcare Venture Summit 2021

Rebirthel participated in the exhibition “Japan Healthcare Venture Summit 2021 (JHVS2021)”, hel...

NEWS , メディア 2021.8.18 Rebirthel was introduced on the web magazine “Nikkei Biotechnology & Business”

“The dictionary of Biotech Startups in Japan 2021-2022” which covers over 400 bio venture compa...

Media , NEWS 2021.7.22 Professor Hiroshi Kawamoto’s research activity was introduced in the TV program “Asa Chan”

Professor Hiroshi Kawamoto, an executive director of Rebirthel, appeared on the morning news pr...

NEWS 2021.6.23 Exhibiting at Arab Health 2021

Professor Hiroshi Kawamoto’s laboratory, Kyoto University, made an exhibition of its research a...

Media , NEWS 2021.6.9 Rebirthel’s research activity to develop a new T cell therapy for the novel coronavirus infection was introduced in the TV program “Hodo Station”

Professor Hiroshi Kawamoto, an executive director of Rebirthel and the Vice Director of Institu...